Given the rich literature on the role of mTOR in age-related diseases and the evidence of its association with advanced biological aging and mental disorders [54–57], it is striking that the methylation and expression levels of a downstream target of mTOR were altered in a sample that increased in psychopathology over time. The gene discussed is MTOR; the disease is psychiatric disorder.